BRPI0811503A2 - Diagnótico de melanoma por análise de ácido nucleico - Google Patents

Diagnótico de melanoma por análise de ácido nucleico

Info

Publication number
BRPI0811503A2
BRPI0811503A2 BRPI0811503-6A2A BRPI0811503A BRPI0811503A2 BR PI0811503 A2 BRPI0811503 A2 BR PI0811503A2 BR PI0811503 A BRPI0811503 A BR PI0811503A BR PI0811503 A2 BRPI0811503 A2 BR PI0811503A2
Authority
BR
Brazil
Prior art keywords
nucleic acid
acid analysis
melanoma diagnosis
melanoma
diagnosis
Prior art date
Application number
BRPI0811503-6A2A
Other languages
English (en)
Inventor
Sherman H Chang
Original Assignee
Dermtech Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermtech Int filed Critical Dermtech Int
Publication of BRPI0811503A2 publication Critical patent/BRPI0811503A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Evolutionary Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Databases & Information Systems (AREA)
  • Artificial Intelligence (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Microbiology (AREA)
  • Evolutionary Computation (AREA)
  • Epidemiology (AREA)
  • Software Systems (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0811503-6A2A 2007-05-04 2008-05-02 Diagnótico de melanoma por análise de ácido nucleico BRPI0811503A2 (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US92780207P 2007-05-04 2007-05-04
US92824807P 2007-05-07 2007-05-07
US98432607P 2007-10-31 2007-10-31
US98468407P 2007-11-01 2007-11-01
US1885008P 2008-01-03 2008-01-03
PCT/US2008/062545 WO2008137772A1 (en) 2007-05-04 2008-05-02 Diagnosis of melanoma by nucleic acid analysis

Publications (1)

Publication Number Publication Date
BRPI0811503A2 true BRPI0811503A2 (pt) 2014-11-18

Family

ID=39939957

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811503-6A2A BRPI0811503A2 (pt) 2007-05-04 2008-05-02 Diagnótico de melanoma por análise de ácido nucleico

Country Status (7)

Country Link
US (1) US20080274908A1 (pt)
EP (2) EP2363505A3 (pt)
AU (1) AU2008247502A1 (pt)
BR (1) BRPI0811503A2 (pt)
CA (1) CA2686212A1 (pt)
NZ (1) NZ580710A (pt)
WO (1) WO2008137772A1 (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
EP2363205A3 (en) 2006-01-11 2014-06-04 Raindance Technologies, Inc. Microfluidic Devices And Methods Of Use In The Formation And Control Of Nanoreactors
EP2530168B1 (en) 2006-05-11 2015-09-16 Raindance Technologies, Inc. Microfluidic Devices
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2077912B1 (en) 2006-08-07 2019-03-27 The President and Fellows of Harvard College Fluorocarbon emulsion stabilizing surfactants
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
BRPI0913578A2 (pt) 2008-05-14 2017-06-06 Dermtech Int diagnose de melanoma e lentigo solar por análise de ácido nucléico
WO2009155310A1 (en) * 2008-06-17 2009-12-23 University Of Rochester Tumor suppression through plexin c1
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
WO2010009365A1 (en) 2008-07-18 2010-01-21 Raindance Technologies, Inc. Droplet libraries
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
US20130143747A1 (en) * 2011-12-05 2013-06-06 Myriad Genetics, Incorporated Methods of detecting cancer
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
EP2517025B1 (en) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Methods for reducing the exchange of molecules between droplets
JP5934657B2 (ja) 2010-02-12 2016-06-15 レインダンス テクノロジーズ， インコーポレイテッド デジタル検体分析
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
EP2539712A4 (en) * 2010-02-26 2013-09-18 Astute Medical Inc METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
WO2012045012A2 (en) 2010-09-30 2012-04-05 Raindance Technologies, Inc. Sandwich assays in droplets
EP3859011A1 (en) 2011-02-11 2021-08-04 Bio-Rad Laboratories, Inc. Methods for forming mixed droplets
EP2675819B1 (en) 2011-02-18 2020-04-08 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
FR2974373B1 (fr) * 2011-04-22 2016-09-02 Oreal Signature moleculaire des taches pigmentaires cutanees, associee a la matrice extracellulaire
CN103619318B (zh) * 2011-04-22 2018-06-05 欧莱雅 和细胞外基质相关的皮肤色斑分子标签
FR2974372B1 (fr) * 2011-04-22 2016-09-02 Oreal Signature moleculaire des taches pigmentaires cutanees, associee au remodelage de la matrice extracellulaire
CN103619317B (zh) * 2011-04-22 2017-06-09 欧莱雅 和细胞外基质结构相关的皮肤色斑分子标签
DE202012013668U1 (de) 2011-06-02 2019-04-18 Raindance Technologies, Inc. Enzymquantifizierung
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
KR101849102B1 (ko) 2011-06-22 2018-04-17 (주)아모레퍼시픽 마이크로 ｒｎａ를 포함하는 색소형성유전자 발현조절용 조성물
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
EP2844768B1 (en) 2012-04-30 2019-03-13 Raindance Technologies, Inc. Digital analyte analysis
US20150140013A1 (en) * 2012-09-21 2015-05-21 The General Hospital Corporation Modulation of asymmetric proliferation
US20160222457A1 (en) 2012-11-14 2016-08-04 Mayo Foundation For Medical Education And Research Methods and materials for identifying malignant skin lesions
EP2986762B1 (en) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
US20160024595A1 (en) * 2014-07-22 2016-01-28 Dermtech International Characterization of melanoma using a molecular signature
WO2016025717A1 (en) * 2014-08-14 2016-02-18 Mayo Foundation For Medical Education And Research Methods and materials for identifying metastatic malignant skin lesions and treating skin cancer
US10709428B2 (en) 2015-05-01 2020-07-14 Dermtech, Inc. Non-invasive skin collection system
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
US11976332B2 (en) 2018-02-14 2024-05-07 Dermtech, Inc. Gene classifiers and uses thereof in non-melanoma skin cancers
CA3099275A1 (en) 2018-05-09 2019-11-14 Dermtech, Inc. Novel gene classifiers and uses thereof in autoimmune diseases
US12473599B2 (en) 2018-07-25 2025-11-18 Skylinedx B.V. Gene signatures for predicting metastasis of melanoma and patient prognosis
AU2020247911A1 (en) 2019-03-26 2021-11-11 Dermtech, Llc Novel gene classifiers and uses thereof in skin cancers
USD989861S1 (en) 2021-02-16 2023-06-20 Dermtech, Inc. Dermatology report document
USD966299S1 (en) 2021-02-16 2022-10-11 Dermtech, Inc. Computer display panel with a graphical user interface for a dermatology report
USD988399S1 (en) 2021-02-16 2023-06-06 Dermtech, Inc. Dermatology report document
USD966300S1 (en) 2021-02-16 2022-10-11 Dermtech, Inc. Computer display panel with a graphical user interface for a dermatology report
USD1061554S1 (en) 2022-09-09 2025-02-11 Dermtech, Llc Computer display panel with a graphical user interface for a dermatology report

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
SE443914B (sv) * 1984-10-01 1986-03-17 Torkel Ingemar Fischer Medel for en overkenslighetstest
US4851510A (en) * 1984-11-30 1989-07-25 Wadley Technologies, Inc. Monoclonal antibodies to novel melanoma-associated antigens
US5460939A (en) * 1986-04-18 1995-10-24 Advanced Tissue Sciences, Inc. Temporary living skin replacement
US4971800A (en) * 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
US5493009A (en) * 1989-11-14 1996-02-20 New York Medical College Antiidiotypic monoclonal antibodies MK2-23 anti-melanomal antibody 763.74
US5583032A (en) * 1992-10-21 1996-12-10 The Cleveland Clinic Foundation And National Institutes Of Health Method of cleaving specific strands of RNA
US5753612A (en) * 1992-10-27 1998-05-19 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US5807522A (en) * 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
IT1278052B1 (it) * 1995-03-14 1997-11-17 Mendes Srl Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per
US6312909B1 (en) * 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
US6054277A (en) * 1996-05-08 2000-04-25 Regents Of The University Of Minnesota Integrated microchip genetic testing system
US5811239A (en) * 1996-05-13 1998-09-22 Frayne Consultants Method for single base-pair DNA sequence variation detection
US6056859A (en) * 1997-02-12 2000-05-02 Lockheed Martin Energy Research Corporation Method and apparatus for staining immobilized nucleic acids
ATE491462T1 (de) * 1998-08-18 2011-01-15 Dermtech Int Methode zum nachweis biologischer faktoren in der epidermis
KR100326937B1 (ko) * 1998-09-23 2002-03-13 정연보 접착성 쉬트로 사람의 표피 ｄｎａ 샘플을 획득하는 방법
US7094533B1 (en) * 1999-01-21 2006-08-22 Board Of Regents Of The University Of Nebraska Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer
US6982089B2 (en) * 1999-02-24 2006-01-03 Tact Ip, Llc Cytokine antagonists for neurological and neuropsychiatric disorders
IL133976A (en) * 2000-01-11 2006-09-05 Dermipsor Ltd Agents for the treatment of skin disorders
JP2005520479A (ja) * 2000-05-09 2005-07-14 ジェネティクス インスティテュート，エルエルシー 乾癬の確認、評価、予防および治療のための組成物、キットおよび方法
EP1176200A3 (de) * 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
US20020132274A1 (en) * 2001-01-17 2002-09-19 Nevalainen Marja T. Diagnostic and monitorings methods for cancer
WO2002098370A2 (en) * 2001-03-02 2002-12-12 Medimmune, Inc. Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
US7297480B2 (en) * 2001-06-28 2007-11-20 Dermtech International Method for detection of melanoma
US20030133936A1 (en) * 2001-07-12 2003-07-17 Byrne Michael Chapman CD25markers and uses thereof
US7247426B2 (en) * 2001-08-02 2007-07-24 Agilent Technologies, Inc. Classifying cancers
US20030113906A1 (en) * 2001-12-14 2003-06-19 Sangha Jangbir S. Method and apparatus for DNA collection
US20030224422A1 (en) * 2002-04-08 2003-12-04 St. Jude Children's Research Hospital, Inc. Pre-and post therapy gene expression profiling to identify drug targets
WO2004024077A2 (en) * 2002-09-11 2004-03-25 Genentech, Inc. Novel composition and methods for the treatment of psoriasis
US20070077553A1 (en) * 2003-10-30 2007-04-05 Rosetta Genomics Bioinformatically detectable group of novel vaccinia regulatory genes and uses thereof
US20040191782A1 (en) * 2003-03-31 2004-09-30 Yixin Wang Colorectal cancer prognostics
WO2005021745A1 (ja) * 2003-08-22 2005-03-10 Nihon University 肝細胞癌に関連する遺伝子
US20050261210A1 (en) * 2004-02-19 2005-11-24 Bhatnagar Rajiv S Nonsense suppressor agents in treatment of cutaneous and gastrointestinal disorders
JP4526839B2 (ja) * 2004-03-05 2010-08-18 株式会社資生堂 角層中の酸化タンパク質を指標とする角層の透明性・保水性を評価する方法
US7183057B2 (en) * 2004-03-31 2007-02-27 Dermtech International Tape stripping methods for analysis of skin disease and pathological skin state
AU2005258000B2 (en) * 2004-06-21 2011-02-03 Progenra Inc. Diagnostic and screening methods and kits associated with proteolytic activity
US7635563B2 (en) * 2004-06-30 2009-12-22 Massachusetts Institute Of Technology High throughput methods relating to microRNA expression analysis
US7608395B2 (en) * 2005-09-15 2009-10-27 Baylor Research Institute Systemic lupus erythematosus diagnostic assay
WO2007124072A2 (en) * 2006-04-20 2007-11-01 Dermtech International Methods for capture and detection of micro-rna molecules from the skin by non-invasive tape stripping
US7615349B2 (en) * 2006-09-07 2009-11-10 H. Lee Moffitt Cancer Center And Research Institute, Inc. Melanoma gene signature
BRPI0913578A2 (pt) * 2008-05-14 2017-06-06 Dermtech Int diagnose de melanoma e lentigo solar por análise de ácido nucléico

Also Published As

Publication number Publication date
EP2152911A1 (en) 2010-02-17
CA2686212A1 (en) 2008-11-13
EP2363505A2 (en) 2011-09-07
US20080274908A1 (en) 2008-11-06
EP2363505A3 (en) 2011-12-21
WO2008137772A1 (en) 2008-11-13
EP2152911A4 (en) 2010-05-19
NZ580710A (en) 2012-06-29
AU2008247502A1 (en) 2008-11-13

Similar Documents

Publication Publication Date Title
EP2152911A4 (en) DIAGNOSIS OF MELANOMA BY NUCLEIC ACID ANALYSIS
EP4024013C0 (en) ANALYSIS SYSTEM
DK2129797T3 (da) Nukleinsyrepåvisning
BRPI0919058A2 (pt) indicador biológico independente
EP3677905C0 (en) INTEGRATED BIOCHIP SYSTEM FOR NUCLEIC ACID ANALYSIS
BRPI0913578A2 (pt) diagnose de melanoma e lentigo solar por análise de ácido nucléico
DK2089159T3 (da) Analyser
BRPI0915058A2 (pt) sistema de coleta de amostra diagnóstica
BRPI0821236A2 (pt) perfurador com duas pontas
EP2263082A4 (en) ANALYSIS OF BLOOD VISCOSITY
EP2335041A4 (en) VEHICLE TEST ARRANGEMENT
EP2372732A4 (en) WAKED ACCUMULATOR
EP2195114A4 (en) INSTRUMENTED PIPETTLE TIP
EP2167945A4 (en) BIOCAPTOR CONFIGURATIONS WAVEGUIDE WITH SILICON PHOTONIC WIRE
EP2284538A4 (en) Biosensor
BRPI0811453A2 (pt) Sistema de análise de amostra
EP2129285A4 (en) Analyte sensor
ATE510923T1 (de) Nukleinsäure
BRPI0921773A2 (pt) indicador de carga
BRPI0820557A2 (pt) biomarcadores diagnósticos de diabetes
EP2280284A4 (en) Biosensor
BRPI0914098A2 (pt) biosensor
BRPI0922957A2 (pt) modificação de vetores de ácido nucleico
EP2368111A4 (en) HONEY ANALYSIS
EP2230301A4 (en) NEW GLUCOSE DEHYDROGENASE

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.